Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type 2 Diabetes in Southwest American Indians
Open Access
- 26 March 2024
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 73 (6) , 1002-1011
Abstract
We sought to identify genetic/immunologic contributors of type 2 diabetes (T2D) in an indigenous American community by genotyping all study participants for both high-resolution HLA-DRB1 alleles and SLC16A11 to test their risk and/or protection for T2D. These genes were selected based on independent reports that HLA-DRB1*16:02:01 is protective for T2D and that SLC16A11 associates with T2D in individuals with BMI <35 kg/m2. Here, we test the interaction of the two loci with a more complete data set and perform a BMI sensitivity test. We defined the risk protection haplotype of SLC16A11, T-C-G-T-T, as allele 2 of a diallelic genetic model with three genotypes, SLC16A11*11, *12, and *22, where allele 1 is the wild type. Both earlier findings were confirmed. Together in the same logistic model with BMI ≥35 kg/m2, DRB1*16:02:01 remains protective (odds ratio [OR] 0.73), while SLC16A11 switches from risk to protection (OR 0.57 [*22] and 0.78 [*12]); an added interaction term was statistically significant (OR 0.49 [*12]). Bootstrapped (b = 10,000) statistical power of interaction, 0.4801, yielded a mean OR of 0.43. Sensitivity analysis demonstrated that the interaction is significant in the BMI range of 30–41 kg/m2. To investigate the epistasis, we used the primary function of the HLA-DRB1 molecule, peptide binding and presentation, to search the entire array of 15-mer peptides for both the wild-type and ancient human SLC16A11 molecules for a pattern of strong binding that was associated with risk and protection for T2D. Applying computer binding algorithms suggested that the core peptide at SLC16A11 D127G, FSAFASGLL, might be key for moderating risk for T2D with potential implications for type 1 diabetes. Article Highlights:Keywords
All Related Versions
Funding Information
- Intramural Research Program of the NIH, NIDDK
This publication has 37 references indexed in Scilit:
- The complete genome sequence of a Neanderthal from the Altai MountainsNature, 2013
- HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionDiabetologia, 2011
- Targeted SNP Genotyping Using the TaqMan® Assay2010
- Molecular variation at the HLA‐A, B, C, DRB1, DQA1, and DQB1 loci in full heritage American Indians in Arizona: private haplotypes and their evolutionTissue Antigens, 2009
- The TaqMan Method for SNP Genotyping2009
- HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes RiskDiabetes, 2008
- An E-M algorithm and testing strategy for multiple-locus haplotypes.1995
- Diabetes mellitus in the pima indians: Incidence, risk factors and pathogenesisDiabetes/Metabolism Research and Reviews, 1990
- DIABETES INCIDENCE AND PREVALENCE IN PIMA INDIANS: A 19-FOLD GREATER INCIDENCE THAN IN ROCHESTER, MINNESOTAAmerican Journal of Epidemiology, 1978
- “Private” Genetic Variants and the Frequency of Mutation Among South American IndiansProceedings of the National Academy of Sciences, 1973